vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (IBCP) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $58.9M, roughly 1.3× INDEPENDENT BANK CORP). Over the past eight quarters, INDEPENDENT BANK CORP's revenue compounded faster (2.1% CAGR vs -34.4%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

IBCP vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.3× larger
MED
$75.1M
$58.9M
IBCP
Faster 2-yr revenue CAGR
IBCP
IBCP
Annualised
IBCP
2.1%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBCP
IBCP
MED
MED
Revenue
$58.9M
$75.1M
Net Profit
$16.9M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
28.6%
Revenue YoY
-36.9%
Net Profit YoY
8.2%
EPS (diluted)
$0.81
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBCP
IBCP
MED
MED
Q1 26
$58.9M
Q4 25
$58.3M
$75.1M
Q3 25
$57.3M
$89.4M
Q2 25
$55.9M
$105.6M
Q1 25
$54.1M
$115.7M
Q4 24
$62.0M
$119.0M
Q3 24
$51.4M
$140.2M
Q2 24
$56.5M
$168.6M
Net Profit
IBCP
IBCP
MED
MED
Q1 26
$16.9M
Q4 25
$18.6M
Q3 25
$17.5M
$-2.3M
Q2 25
$16.9M
$2.5M
Q1 25
$15.6M
$-772.0K
Q4 24
$18.5M
Q3 24
$13.8M
$1.1M
Q2 24
$18.5M
$-8.2M
Gross Margin
IBCP
IBCP
MED
MED
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
IBCP
IBCP
MED
MED
Q1 26
Q4 25
34.8%
-10.4%
Q3 25
37.0%
-4.6%
Q2 25
37.0%
-1.0%
Q1 25
35.3%
-1.1%
Q4 24
36.7%
0.6%
Q3 24
33.7%
1.5%
Q2 24
41.0%
-4.7%
Net Margin
IBCP
IBCP
MED
MED
Q1 26
28.6%
Q4 25
31.8%
Q3 25
30.5%
-2.5%
Q2 25
30.2%
2.3%
Q1 25
28.8%
-0.7%
Q4 24
29.8%
Q3 24
26.9%
0.8%
Q2 24
32.8%
-4.8%
EPS (diluted)
IBCP
IBCP
MED
MED
Q1 26
$0.81
Q4 25
$0.88
$-1.64
Q3 25
$0.84
$-0.21
Q2 25
$0.81
$0.22
Q1 25
$0.74
$-0.07
Q4 24
$0.87
$0.08
Q3 24
$0.65
$0.10
Q2 24
$0.88
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBCP
IBCP
MED
MED
Cash + ST InvestmentsLiquidity on hand
$174.9M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.6M
$198.9M
Total Assets
$5.6B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBCP
IBCP
MED
MED
Q1 26
$174.9M
Q4 25
$138.4M
$167.3M
Q3 25
$208.7M
$173.5M
Q2 25
$146.2M
$162.7M
Q1 25
$128.1M
$164.6M
Q4 24
$119.9M
$162.3M
Q3 24
$121.6M
$170.0M
Q2 24
$214.3M
$163.5M
Stockholders' Equity
IBCP
IBCP
MED
MED
Q1 26
$510.6M
Q4 25
$503.0M
$198.9M
Q3 25
$490.7M
$214.7M
Q2 25
$469.3M
$216.0M
Q1 25
$467.3M
$211.0M
Q4 24
$454.7M
$210.1M
Q3 24
$452.4M
$207.3M
Q2 24
$430.5M
$205.3M
Total Assets
IBCP
IBCP
MED
MED
Q1 26
$5.6B
Q4 25
$5.5B
$248.0M
Q3 25
$5.5B
$268.2M
Q2 25
$5.4B
$269.3M
Q1 25
$5.3B
$280.0M
Q4 24
$5.3B
$284.2M
Q3 24
$5.3B
$291.2M
Q2 24
$5.3B
$293.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBCP
IBCP
MED
MED
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBCP
IBCP
MED
MED
Q1 26
Q4 25
$76.7M
$-5.3M
Q3 25
$18.2M
$12.1M
Q2 25
$19.0M
$-3.4M
Q1 25
$31.7M
$3.4M
Q4 24
$63.2M
$-4.9M
Q3 24
$17.2M
$9.1M
Q2 24
$8.7M
$13.1M
Free Cash Flow
IBCP
IBCP
MED
MED
Q1 26
Q4 25
$70.2M
$-6.6M
Q3 25
$16.5M
$10.8M
Q2 25
$16.7M
$-4.8M
Q1 25
$30.6M
$1.9M
Q4 24
$55.2M
$-7.2M
Q3 24
$15.7M
$7.7M
Q2 24
$7.0M
$11.1M
FCF Margin
IBCP
IBCP
MED
MED
Q1 26
Q4 25
120.3%
-8.8%
Q3 25
28.9%
12.0%
Q2 25
29.8%
-4.5%
Q1 25
56.5%
1.6%
Q4 24
89.1%
-6.1%
Q3 24
30.6%
5.5%
Q2 24
12.3%
6.6%
Capex Intensity
IBCP
IBCP
MED
MED
Q1 26
Q4 25
11.1%
1.8%
Q3 25
2.9%
1.5%
Q2 25
4.1%
1.3%
Q1 25
2.1%
1.3%
Q4 24
12.8%
1.9%
Q3 24
2.9%
1.0%
Q2 24
3.1%
1.1%
Cash Conversion
IBCP
IBCP
MED
MED
Q1 26
Q4 25
4.13×
Q3 25
1.04×
Q2 25
1.12×
-1.36×
Q1 25
2.03×
Q4 24
3.42×
Q3 24
1.25×
8.04×
Q2 24
0.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBCP
IBCP

Net Interest Income$46.9M80%
Noninterest Income$12.0M20%

MED
MED

Segment breakdown not available.

Related Comparisons